Fei Chen is a Vice President at TPG Capital based in San Francisco, where she focuses on investments in the healthcare sector. Fei has served on the Board of Directors of Neogene Therapeutics and has been involved in TPG’s investments in Allogene Therapeutics, Kelsey-Seybold Clinic, LifeStance Health, Exactech and Kadiant. Prior to joining TPG in 2017, Fei was an Associate at Altaris Capital Partners and an Analyst at Jefferies LLC in its investment banking division. Fei graduated cum laude and with distinction from Duke University with a B.A. in Public Policy.